It has been believed that for years, diets low in saturated fat can help to not only decrease the risk of heart disease but to also lengthen longevity as well. However, new studies show, that might not be the case.
Type 2 Diabetes affects over 300 million people globally and that number increases every year. While many people can adjust their lifestyles or even take medication to control diabetes, there is no cure for diabetes as a whole. However, medical science has come far in recent years in finding a better way to manage blood sugar.
Most people look at nutrition labels and become quite confused about what is actually in the foods they are buying. Due to a new makeover, confusing nutrition labels just might be a thing of the past.
The Food and Drug Administration announced on February 27th, 2014 that there is a proposed change to nutrition labels, which will be the very first overhaul in over 20 years. The new labels proposed will show more calories and added sugars. This will make calorie counting easier while helping to highlight those sneaky sugars that slide right past the radar. It will also change required serving sizes like soda.
An estimated 25.8 million Americans have diabetes, and seven million of those may not be diagnosed has been recorded by the National Diabetes Information Clearinghouse.
While many women find a need to exercise religiously, it may not be helping as much as they think. Researchers reveal that moderate exercise decreases risk of stroke in women. In fact, moderate exercise such as playing tennis or walking briskly can cut a woman’s stroke risk by 20 percent while also helping to offset the increased risk of a possible stroke caused by postmenopausal hormone therapy.
Scientists as the Gladstone Institutes are looking into the power of regenerative medicine. Through the use of animal models, scientists have developed a technique that shows skin cells creating insulin-producing cells. The long term goal of this new study is to assist people who have been diagnosed with Type 1 diabetes to find a way to treat their diabetes without the use of life-long injections.
Diabetic retinopathy, a leading cause in adult blindness affects more than a quarter of adults with diabetes and threatens the vision of an estimated 600,000 more in the United States. However, there may now be new treatment options available as a new study shows treatment for diabetic retinopathy.
Dopamine-restoring drugs which are currently used to treat Parkinson’s disease may an answer where blindness happens due to diabetic retinopathy.
Studies have been implemented on diabetic mice to test their vision. Researchers are currently assessing mice for their ability to follow patterns of lines projected impelled around them.
Previously, doctors believed that the impairment behind retinopathy came from the damage of blood vessels due to high blood sugar spikes and they also knew that dopamine was important to the retina since it’s a vital neurotransmitter in the brain. However,Machelle Pardue, PhD, associate professor of ophthalmology at Emory University School of Medicine and research career scientist at the Atlanta VA Medical Center has this to say on the matter, “There was some evidence already that dopamine levels were reduced in diabetic retinopathy, but what’s new here is: we can restore dopamine levels and improve visual function in an animal model of diabetes.”
MD/PhD student Moe Aung and senior authors of this study, Pardue and P. Michael Iuvone, PhD, professor of ophthalmology and pharmacology and director of vision research at Emory Eye Center, examined diabetic mice, treating them with streptozocin which is lethal to insulin-producing cells in the pancreas. By injecting the mince with L-DOPA, a common drug to treat Parkinson’s disease, once they had received streptozocian, researchers found that visual problems seized by weeks and lessened the severity of visual defects. It was also found that the visual benefits of L-DOPA derived from the retinas, which was measured by electroretinography.
The tests to assess vision was created when mice were placed on a platform and measured for their ability to move their heads in response to a rotating pattern of vertical lines, which were projected on a cylinder around the mouse.
Iuvone states, “This is important because it shows that treatments targeting dopamine could be beneficial to patients with established diabetes. It should be straightforward to try L-DOPA or dopamine receptor agonist treatment in adults, although L-DOPA could have complications in children. Bromocriptine, a dopamine receptor agonist, is already FDA-approved to treat type 2 diabetes. It will be important to determine if the same dopamine receptors modulate acuity and contrast sensitivity in humans.”
The free glucose meter offer is back on our website. From time to time we get these offers and post them when they become available. It’s been a while since we’ve had one so we wanted to let everyone know. The offer is good for US residents that are under the age of 65. This promotion is going through a third party company and any questions can go through them after you sign up.
We’ll post these free glucose meter offers as they come up. We’ve seen these types off offers come and go so check back if there is no offer presently.
To sign up using our secure form, please visit https://www.diabeticlive.com/free-glucose-meter/
New Study Results on Cancer & Pre-Diabetic Patients
Pre-diabetic patients with vascular disorders are found to have particular genetic or chromosomal oddity on the preleukemic condition. This result is now clearing the relation of cancer among individuals with pre-diabetes and was gathered by a renowned French-British-Qatari group led by Professor Philippe Froguel.
Found in the official website of National Genetics is the copy of this work published on 14th July, 2013.
FDA Warns 15 Companies Selling Herbal & Natural Supplements For Diabetes
Fifteen companies, both within the U.S. and abroad, have been issued warnings by the Food and Drug Administration ordering them to stop selling diabetes treatments online and in stores that violate U.S. drug laws.
One example is Diexi, which is sold as a natural supplement, a product made by Amrutam Life Care of Surat, India. Diexi is sold as an Indian herbal remedy, but Diexi contains metformin, the most common prescription drug used to treat Type 2 diabetes.